Literature DB >> 22088938

A pilot test of a combined tobacco dependence treatment and lung cancer screening program.

Amy K Ferketich1, Gregory A Otterson, Mark King, Nathan Hall, Kristine K Browning, Mary Ellen Wewers.   

Abstract

Lung cancer screening with computed tomography has demonstrated a significant reduction in mortality. While these findings are important for the lung cancer research field, the most important risk factor for lung cancer, i.e. smoking, should not be ignored. We performed a pilot study to examine the feasibility of delivering a program that included both tobacco dependence treatment and lung cancer screening. The objectives of this study were to: (1) estimate the proportion of smokers who complied with a 12-week treatment protocol that included both tobacco dependence treatment and lung cancer screening, (2) obtain preliminary estimates of abstinence and quit attempts at 4 and 6 months, and (3) obtain preliminary estimates of the cognitive social health information processing (C-SHIP) constructs and how they change following the intervention. In this randomized pilot study, 18 volunteers completed a 12-week protocol: half received the tobacco dependence treatment program before a CT scan (BCT) and the other received the CT scan first, followed by the treatment program (ACT). The treatment protocol included both nurse-delivered telephone counseling and either nicotine replacement therapy or varenicline. Only one person did not complete all follow-up evaluations. At 4 months post enrollment, the carbon monoxide confirmed quit rates were 33.3% in the BCT arm and 22.2% in the ACT arm (27.8% overall), and all but one had made a 24-h attempt to quit. At 6 months the confirmed abstinence decreased to 22.1% in the BCT arm and 11.1% in the ACT arm (16.7% overall), and 72.2% of participants had made a 24-h quit attempt. These preliminary results suggest that it might be better to deliver treatment before the screening test. Future randomized trials with a larger sample size are needed to confirm these findings.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088938      PMCID: PMC4272196          DOI: 10.1016/j.lungcan.2011.10.011

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  27 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Longitudinal predictors of continued tobacco use among patients diagnosed with cancer.

Authors:  Robert A Schnoll; Calvin James; Michael Malstrom; Randi L Rothman; Hao Wang; James Babb; Suzanne M Miller; John A Ridge; Benjamin Movsas; Corey Langer; Michael Unger; Melvyn Goldberg
Journal:  Ann Behav Med       Date:  2003

3.  Change in smoking status after spiral chest computed tomography scan screening.

Authors:  Lisa Sanderson Cox; Matthew M Clark; James R Jett; Christi A Patten; Darrell R Schroeder; Liza M Nirelli; Stephen J Swensen; Richard D Hurt
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

4.  Worry about health in smoking behaviour change.

Authors:  A Dijkstra; J Brosschot
Journal:  Behav Res Ther       Date:  2003-09

5.  Effectiveness of smoking cessation self-help materials in a lung cancer screening population.

Authors:  Matthew M Clark; Lisa Sanderson Cox; James R Jett; Christi A Patten; Darrell R Schroeder; Liza M Nirelli; Kristin Vickers; Richard D Hurt; Stephen J Swensen
Journal:  Lung Cancer       Date:  2004-04       Impact factor: 5.705

Review 6.  Motivation to quit using cigarettes: a review.

Authors:  Kevin D McCaul; Jill R Hockemeyer; Rebecca J Johnson; Kimberlee Zetocha; Kathryn Quinlan; Russell E Glasgow
Journal:  Addict Behav       Date:  2006-01       Impact factor: 3.913

7.  Smoking cessation following CT screening for early detection of lung cancer.

Authors:  J S Ostroff; N Buckshee; C A Mancuso; D F Yankelevitz; C I Henschke
Journal:  Prev Med       Date:  2001-12       Impact factor: 4.018

8.  Decisional balance measure for assessing and predicting smoking status.

Authors:  W F Velicer; C C DiClemente; J O Prochaska; N Brandenburg
Journal:  J Pers Soc Psychol       Date:  1985-05

9.  Psychological issues related to the use of spiral CT for lung cancer early detection.

Authors:  Robert A Schnoll; Pamela Bradley; Suzanne M Miller; Michael Unger; James Babb; Mark Cornfeld
Journal:  Lung Cancer       Date:  2003-03       Impact factor: 5.705

10.  Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development.

Authors:  Robert A Schnoll; Suzanne M Miller; Michael Unger; Cecilia McAleer; Theresa Halbherr; Pamela Bradley
Journal:  Lung Cancer       Date:  2002-09       Impact factor: 5.705

View more
  29 in total

1.  Examining Gender Differences in Lung Cancer Screening.

Authors:  Simran Randhawa; Shelby R Sferra; Chandra Das; Larry R Kaiser; Grace X Ma; Cherie P Erkmen
Journal:  J Community Health       Date:  2020-10

Review 2.  Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.

Authors:  Lisa M Fucito; Sharon Czabafy; Peter S Hendricks; Chris Kotsen; Donna Richardson; Benjamin A Toll
Journal:  Cancer       Date:  2016-02-24       Impact factor: 6.860

3.  Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States.

Authors:  Pianpian Cao; Jihyoun Jeon; David T Levy; Jinani C Jayasekera; Christopher J Cadham; Jeanne S Mandelblatt; Kathryn L Taylor; Rafael Meza
Journal:  J Thorac Oncol       Date:  2020-03-08       Impact factor: 15.609

4.  Tobacco cessation in lung cancer screening-do we have the evidence?

Authors:  Emily Stone; Henry Marshall
Journal:  Transl Lung Cancer Res       Date:  2018-09

5.  Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Authors:  Kathryn L Taylor; Charlotte J Hagerman; George Luta; Paula G Bellini; Cassandra Stanton; David B Abrams; Jenna A Kramer; Eric Anderson; Shawn Regis; Andrea McKee; Brady McKee; Ray Niaura; Harry Harper; Michael Ramsaier
Journal:  Lung Cancer       Date:  2017-02-15       Impact factor: 5.705

Review 6.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

7.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Authors:  Renda Soylemez Wiener; Michael K Gould; Douglas A Arenberg; David H Au; Kathleen Fennig; Carla R Lamb; Peter J Mazzone; David E Midthun; Maryann Napoli; David E Ost; Charles A Powell; M Patricia Rivera; Christopher G Slatore; Nichole T Tanner; Anil Vachani; Juan P Wisnivesky; Sue H Yoon
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

Review 8.  The importance of incorporating smoking cessation into lung cancer screening.

Authors:  Jennifer Anne Minnix; Maher Karam-Hage; Janice A Blalock; Paul M Cinciripini
Journal:  Transl Lung Cancer Res       Date:  2018-06

9.  Importance of Smoking Cessation in a Lung Cancer Screening Program.

Authors:  Vidit Munshi; Pamela McMahon
Journal:  Curr Surg Rep       Date:  2013-12

Review 10.  Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis.

Authors:  Danhong Chen; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2015-06-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.